Genomic Health, Inc
|
||
(Name of Issuer)
|
||
Common Stock, par value $0.0001 per share
|
||
(Title of Class of Securities)
|
||
37244C101
|
||
(CUSIP Number)
|
||
Leo Kirby
667 Madison Avenue, 21st Floor
New York, NY 10065
(212) 339-5633
|
||
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
||
March 2, 2011
|
||
(Date of Event which Requires Filing of this Statement)
|
CUSIP No. 37244C101
|
Page 2 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Julian C. Baker
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
(b) ¨
|
|
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
41,250
|
8
|
SHARED VOTING POWER
7,212,569
|
|
9
|
SOLE DISPOSITIVE POWER
41,250
|
|
10
|
SHARED DISPOSITIVE POWER
7,212,569
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,253,819
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.1%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 37244C101
|
Page 3 of 8 Pages
|
1
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Felix J. Baker
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a) ¨
(b) ¨
|
3
|
SEC USE ONLY
|
|
4
|
SOURCE OF FUNDS (See Instructions)
WC
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
7,212,569
|
|
9
|
SOLE DISPOSITIVE POWER
0
|
|
10
|
SHARED DISPOSITIVE POWER
7,212,569
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,212,569
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(See Instructions) |
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.0%
|
|
14
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
Item 5.
|
Interest in Securities of the Issuer.
|
Name
|
Number of
Shares
|
Percent of Class
Outstanding
|
||||||
Baker Bros. Investments, L.P.
|
173,897 | 0.6 | % | |||||
Baker Bros. Investments II, L.P.
|
20,287 | 0.1 | % | |||||
667, L.P.
|
1,253,653 | 4.3 | % | |||||
Baker Brothers Life Sciences, L.P.
|
5,253,682 | 18.2 | % | |||||
14159, L.P.
|
142,992 | 0.5 | % | |||||
FBB Associates
|
173,897 | 0.6 | % | |||||
Baker/Tisch Investments, L.P.
|
194,161 | 0.7 | % | |||||
Julian C. Baker
|
41,250 | 0.1 | % | |||||
Total
|
7,253,819 | 25.1 | % |
Name
|
Date
|
Number of
|
||||||||
Shares
|
Transaction
|
Price / Share
|
||||||||
Baker Brothers Life Sciences, L.P.
|
2/23/11
|
33,009 |
Purchase
|
22.8775 | ||||||
14159, L.P.
|
2/23/11
|
911 |
Purchase
|
22.8775 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/23/11
|
15,333 |
Purchase
|
22.8801 | ||||||
14159, L.P.
|
2/23/11
|
423 |
Purchase
|
22.8801 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/23/11
|
2,393 |
Purchase
|
22.8691 | ||||||
14159, L.P.
|
2/23/11
|
66 |
Purchase
|
22.8691 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/24/11
|
48,224 |
Purchase
|
23.4284 | ||||||
14159, L.P.
|
2/24/11
|
1,331 |
Purchase
|
23.4284 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/24/11
|
24,318 |
Purchase
|
23.4718 | ||||||
14159, L.P.
|
2/24/11
|
671 |
Purchase
|
23.4718 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/25/11
|
8,195 |
Purchase
|
23.9451 | ||||||
14159, L.P.
|
2/25/11
|
226 |
Purchase
|
23.9451 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/25/11
|
12,897 |
Purchase
|
23.8855 | ||||||
14159, L.P.
|
2/25/11
|
356 |
Purchase
|
23.8855 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/25/11
|
13,986 |
Purchase
|
24.2324 | ||||||
14159, L.P.
|
2/25/11
|
386 |
Purchase
|
24.2324 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/28/11
|
18,661 |
Purchase
|
25.0433 | ||||||
14159, L.P.
|
2/28/11
|
515 |
Purchase
|
25.0433 | ||||||
Baker Brothers Life Sciences, L.P.
|
2/28/11
|
23,495 |
Purchase
|
25.1409 | ||||||
14159, L.P.
|
2/28/11
|
649 |
Purchase
|
25.1409 | ||||||
Baker Brothers Life Sciences, L.P.
|
3/1/11
|
681 |
Purchase
|
25.5407 | ||||||
14159, L.P.
|
3/1/11
|
19 |
Purchase
|
25.5407 | ||||||
Baker Brothers Life Sciences, L.P.
|
3/1/11
|
23,545 |
Purchase
|
25.5657 | ||||||
14159, L.P.
|
3/1/11
|
650 |
Purchase
|
25.5657 | ||||||
Baker Brothers Life Sciences, L.P.
|
3/1/11
|
18,986 |
Purchase
|
25.5576 | ||||||
14159, L.P.
|
3/1/11
|
524 |
Purchase
|
25.5576 | ||||||
Baker Brothers Life Sciences, L.P.
|
3/2/11
|
28,602 |
Purchase
|
25.9963 | ||||||
14159, L.P.
|
3/2/11
|
789 |
Purchase
|
25.9963 | ||||||
Baker Brothers Life Sciences, L.P.
|
3/2/11
|
46,367 |
Purchase
|
26.1571 | ||||||
14159, L.P.
|
3/2/11
|
1,280 |
Purchase
|
26.1571 |
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7.
|
Material to Be Filed as Exhibits.
|
Exhibit 1.
|
Agreement regarding the joint filing of this statement.
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|
By:
|
/s/ Julian C. Baker
|
|
Julian C. Baker
|
||
By:
|
/s/ Felix J. Baker
|
|
Felix J. Baker
|